Medical Providers

This web page provides frequently asked questions regarding the 2023 Medication Access and Training Expansion (MATE) Act which requires new or renewing DEA licensees to have completed a total of at least eight hours of training on opioid or other substance use disorders and the appropriate treatment of pain.

This letter announces details on the 2023 Medication Access and Training Expansion (MATE) Act which requires new or renewing DEA licensees to have completed a total of at least eight hours of training on opioid or other substance use disorders and the appropriate treatment of pain.

This web page provides frequently asked questions regarding the 2023 Consolidated Appropriations Act, which eliminates the X-waiver (DATA-Waiver) and increases accessibility of medication-assisted treatment (MAT).

This webinar discusses trends in THC potency and delivery and their systems, marijuana risks for developing fetal brain systems and adolescent brain, and what to do with this information.

This toolkit helps users evaluate their organization's diversity and cultural competence through a step-by-step process.

This letter announces details on Congress's elimination of the X-waiver (DATA-Waiver) to increase buprenorphine accessibility in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).

This guidance document provides information regarding issuance of updated DEA registration certificates to reflect Congress’s elimination of the X-waiver (DATA-Waiver) in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).

Part 2 of this two-part series features a panel presentation of experts discussing how and why the system of inequity exists. Panelists share the fundamental causes of health disparities and recommendations to the field on responding to health disparities in substance misuse prevention.

This handout is designed to assist both newly formed and seasoned prevention coalitions to determine the who, what, and how to reduce health disparities as they implement substance misuse prevention programs.

This virtual five-part learning community is for prevention professionals working in communities of color. It discusses best practices for delivering culturally competent services, prevention’s role in eliminating systemic and structural barriers to wellness, substance use disorder, and much more.